Diagnostic Performance of a Rapid Point-of-care Test for SARS-CoV-2 in an Urban Emergency Department Setting
Detection Principle
NucleicAcid-PCR based
Target
/
Testing Method Category
PCR_KIT
Testing Method
ID NOW SARS?CoV?2 Assay
Testing Method - Additional Info
retrospective analysis of data to evaluate the Performance of ID NOW SARS?CoV?2 Assay Compared to the m2000 (Abbott Molecular)
Reported Performance
sensitivity: 78.8% ; specificity: 98.7%
Sample Size
597 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements